Lipigon Pharmaceuticals (Sweden) Analysis
| LPGO Stock | SEK 0.19 0.01 5.00% |
Lipigon Pharmaceuticals AB is overvalued with Real Value of 0.17 and Hype Value of 0.19. The main objective of Lipigon Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Lipigon Pharmaceuticals AB is worth, separate from its market price. There are two main types of Lipigon Pharmaceuticals' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Lipigon Pharmaceuticals' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Lipigon Pharmaceuticals' stock to identify patterns and trends that may indicate its future price movements.
The Lipigon Pharmaceuticals stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Lipigon Pharmaceuticals is usually not traded on St . John 's Day, NationalDay, All Saints ' Day, Christmas Eve, Christmas Day, Boxing Day, New Year 's Day, Epiphany, Good Friday, Easter Sunday, Easter Monday, International Workers ' Day. Lipigon Stock trading window is adjusted to Europe/Stockholm timezone.
Lipigon |
Lipigon Stock Analysis Notes
About 38.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.62. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Lipigon Pharmaceuticals recorded a loss per share of 4.65. The entity had not issued any dividends in recent years. Lipigon Pharmaceuticals AB develops drugs for lipid related diseases in Sweden. Lipigon Pharmaceuticals AB was founded in 2010 and is based in Ume, Sweden. Lipigon Pharmaceuticals is traded on Stockholm Stock Exchange in Sweden. To find out more about Lipigon Pharmaceuticals AB contact Stefan Nilsson at 46 7 05 78 17 68 or learn more at https://www.lipigon.se.Lipigon Pharmaceuticals Investment Alerts
| Lipigon Pharmaceuticals generated a negative expected return over the last 90 days | |
| Lipigon Pharmaceuticals has high historical volatility and very poor performance | |
| Lipigon Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Lipigon Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 3.18 M. Net Loss for the year was (41.11 M) with loss before overhead, payroll, taxes, and interest of (36.04 M). | |
| Lipigon Pharmaceuticals AB has accumulated about 58.95 M in cash with (35.3 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.06, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 38.0% of the company outstanding shares are owned by corporate insiders |
Lipigon Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 25.81 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Lipigon Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Lipigon Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 12th of December 2024, Lipigon Pharmaceuticals secures the Mean Deviation of 5.21, risk adjusted performance of 0.0014, and Standard Deviation of 7.67. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lipigon Pharmaceuticals, as well as the relationship between them.Lipigon Pharmaceuticals Price Movement Analysis
The output start index for this execution was fourty-one with a total number of output elements of twenty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Lipigon Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Lipigon Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Lipigon Pharmaceuticals Outstanding Bonds
Lipigon Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Lipigon Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Lipigon bonds can be classified according to their maturity, which is the date when Lipigon Pharmaceuticals AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Lipigon Pharmaceuticals Predictive Daily Indicators
Lipigon Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Lipigon Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 35173.58 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 0.19 | |||
| Day Typical Price | 0.19 | |||
| Period Momentum Indicator | (0.01) |
Lipigon Pharmaceuticals Forecast Models
Lipigon Pharmaceuticals' time-series forecasting models are one of many Lipigon Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Lipigon Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Lipigon Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Lipigon Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Lipigon shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Lipigon Pharmaceuticals. By using and applying Lipigon Stock analysis, traders can create a robust methodology for identifying Lipigon entry and exit points for their positions.
Lipigon Pharmaceuticals AB develops drugs for lipid related diseases in Sweden. Lipigon Pharmaceuticals AB was founded in 2010 and is based in Ume, Sweden. Lipigon Pharmaceuticals is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Lipigon Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Additional Tools for Lipigon Stock Analysis
When running Lipigon Pharmaceuticals' price analysis, check to measure Lipigon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipigon Pharmaceuticals is operating at the current time. Most of Lipigon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lipigon Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipigon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lipigon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.